Sort
21,453 grants matching “tuberculosis”
Tuberculosis Imaging Program
$2,320,134Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
Development of a Recombinant Tuberculosis Vaccine
$2,316,340Corixa Corporation · UC1 · FY2000 · AI
Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis
$2,312,751Antonino None Catanzaro · University Of California, San Diego · U01 · FY2012 · AI
Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis
$2,312,396Antonino None Catanzaro · University Of California, San Diego · U01 · FY2010 · AI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,310,807Shahin Lockman · Harvard School Of Public Health · UM1 · FY2020 · AI
Stem Cell-Engineered Invariant Natural Killer T Cells for Cancer Therapy
$2,310,000Lili Yang · University Of California Los Angeles · DP2 · FY2014 · CA
DYNAMIC NUCLEAR POLARIZATION SOLID STATE NMR SPECTROMETER FOR BIOMOLECULAR STUDIE
$2,309,300Ann E McDermott · New York Structural Biology Center · S10 · FY2010 · RR
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$2,308,478Kathy Penrose · Houston Department/Health/Human Srvs · U52 · FY2009 · PS
The intersection of innate and adaptive immunity to intracellular pathogens
$2,307,757Daniel A Portnoy · University Of California Berkeley · P01 · FY2021 · AI
Center for Experimental Infectious Disease Research
$2,305,000Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2010 · RR
Transmission and virulence of Mycobacterium tuberculosis
$2,303,000Kathryn Deriemer · University Of California At Davis · DP2 · FY2010 · OD
Activities Of Chemokines In Health and Disease
$2,301,894Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Simian Vaccine Evaluation Units
$2,300,238Mark Lewis · Bioqual, Inc. · N01 · FY2011 · AI
Systems Genetics of Tuberculosis
$2,300,000Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2017 · AI
SPORE in Bladder Cancer
$2,299,837Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$2,297,949Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,293,769Dartmouth College · P20 · FY2001 · RR
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,292,400W. Henry Henry Boom · Case Western Reserve University · R01 · FY2016 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$2,289,159Carole D Mitnick · Harvard Medical School · U01 · FY2013 · AI
Center for Experimental Infectious Disease Research
$2,284,780Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2012 · GM
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,284,358Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$2,282,918William S Paul · Chicago Department Of Public Health · U52 · FY2006 · PS
Center for Experimental Infectious Disease Research
$2,281,950Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2011 · RR
MIDAS Center for Communicable Disease Dynamics
$2,279,902Marc Lipsitch · Harvard School Of Public Health · U54 · FY2014 · GM
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$2,276,696Catherine C McGowan · Vanderbilt University · U01 · FY2014 · AI